ArticleHemaSphere2022

Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals.

Ioannis Ntanasis-Stathopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.